PRIMARY GASTRIC LYMPHOMA IN A PROSPECTIVE STUDY

Authors

  • Petruta Violeta FILIP “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • Sorina DIACONU “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania
  • Paraschiva POSTOLACHE “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania
  • Corina Silvia POP “Carol Davila” University of Medicine and Pharmacy, Bucharest

Abstract

PRIMARY GASTRIC LYMPHOMA IN A PROSPECTIVE STUDY (Abstract). Aim: To assess the of occurrence of primary gastric lymphoma using epidemiological, clinical and biological data. This rare pathology includes more different histological subtypes that can affect different segments of gastrointestinal tract. Material and methods: Retrospective analysis of the hospital-based medical records of patients with primary gastrointestinal lymphoma admitted in the Hematology Clinic of the University Emergency Hospital of Bucharest between October 2014 and June 2018. The analyzed data included demographic data, Helicobacter pylori infection, disease staging, laboratory tests and objective examination. All the patients made a CT scan of the chest, abdomen and pelvis. The histological diagnosis was based on biopsy specimens in performing upper digestive endoscopy and immunohistochemistry. All data was statistically analyzed using STATA 13 (Stata Corp LLC US). Results: This study included 21 patients that have been diagnosed with primary gastrointestinal lymphoma. It was observed that primary gastric lymphoma frequently affects more females than males. Histopathological, the majority of primary gastric lymphoma (90.41%) were B-cell lineage and diffuse large B-cell occurred in 66.66% of cases. Out of the 21 patients surveyed, 13 (61.90%) presented loss of appetite, 9 (42.85%) had abdominal pain. Anemia was present in 16 cases. Conclusions: The majority cases in our study were diffuse large B-cell lymphoma which were related to infection with Helicobacter pylori in half the cases.

Author Biographies

  • Petruta Violeta FILIP, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Faculty of Medicine
    Department of Internal Medicine III
    Emergency University Hospital, Bucharest

  • Sorina DIACONU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

    Faculty of Medicine
    Department of Internal Medicine III
    Emergency University Hospital, Bucharest

  • Paraschiva POSTOLACHE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

    Faculty of Medicine
    Department of Medical Specialties (I)
    Clinical Rehabilitation Hospital, Iasi

  • Corina Silvia POP, “Carol Davila” University of Medicine and Pharmacy, Bucharest

    Faculty of Medicine
    Department of Internal Medicine III
    Emergency University Hospital, Bucharest

References

1. Jantea P, Nemeş RM, Pop CS. Pathophysiological Correlations in Gastro-Intestinal Lymphomas. Roumanian J Anatomy 2015; 14(3): 538-548.
2. Pop CS, et al. A rare complication of CMV infection in Crohn’s disease-hemophagocytic syndrome: a case report. Embryol RJM 2015; 56(4): 1535-1540.
3. Juárez-Salcedo LM, et al. Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treat-ment. Cancer Control 2018; 25(1): 4-8.
4. Zullo A, et al. Gastric MALT lymphoma: Old and new insights. Ann Gastroenterol 2014; 27(1): 27-33.
5. Cardona DM, Layne A, Lagoo AS. Lymphomas of the gastro-intestinal tract: pathophysiology, pa-thology, and differential diagnosis. Indian J Pathol Microbiol 2012; 55(1): 1-16.
6. Ronchi A, Montella M, Panarese I, et al. MALT gastric lymphoma: An update of pathogenetic features. WCRJ 2016; 3(2): 1-10.
7. Ferri GM, Specchia G, Mazza P, et al. Risk of lymphoma subtypes by occupational exposure in Southern Italy. J Occup Med Toxicol 2017; 12(31): 10-15.
8. Otelea MR, Arghir OC, Zugravu C, Naghi E, Antoniu S, Rașcu A. Lung function and quality of life in workers with chemical and dust exposure. Rev Chem 2018; 69(2): 346-349.
9. Constantin DA, Cioriceanu IH, Ţânţu MM, Popa D, Bădău D, Burtea V, Nemet GC, Rogozea LM. Ethical dilemmas in communicating bad news following histopathology examination. Rom J Morphol Embryol 2017; 58(3): 1121-1125.
10. Constantin DA, Cioriceanu IH, Ţânţu MM, Popa D, Bădău D, Burtea V, Nemet GC, Rogozea LM. Ethical dilemmas in communicating bad news following histopathology examination. Rom J Morphol Embryol 2017; 58(3): 1121-1125.
11. Ruskoni-Fourmestraux A, Aegerter P, Galian A, Delmer A. Primary Digestive Tract Lymphoma: A Prospective Multicentric Study of 91 Patients. Gastroenterology 1993; 105: 1662-1671.
12. Chairman PPC, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’ s Disease Staging Classification. Cancer Res 1971; 31(11): 1860-1861.
13. Copie-Bergman C, Wotherspoon C, Capella C, et al. Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol 2013; 160(1): 47-52.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
15. Matysiak-Budnik T, Fabiani B, Hennequin C, et al. Gastrointestinal lymphomas : French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up. SNFGE 2018; 50: 124-131.
16. Vetro C, Romano A, Amico I, et al. Endoscopic features of gastro-intestinal lymphomas: From diag-nosis to follow-up. World J Gastroenterol 2014; 20(36): 12993-13005.
17. Schizas D, Ntanasis-stathopoulos I, Tsilimigras DI, et al. The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma. Gastroenterol Res Pract 2017; 14-18.
18. Malipatel R, Primary Gastric Lymphoma: Clinicopathological Profile. Euroasian J Hepatogastroenterol 2018; 8(1): 6-10.
19. Nitu FM, Olteanu M, Streba CT, et al. Tuberculosis and its particularities in Romania and worldwide. Romanian J Morphol Embryol 2017; 58(2): 385-392.
20. Pop CS, Pomohaci C, Iucu R, et al. Prevalence of alcohol - related medical problems among excessive and heavy drinking women in a Romanian Emergency Hospital. Rev Cercetare si Interventie Sociala 2015; 51: 41-45.
21. Nitescu M, Furtunescu FL, Otelea M, et al. Prevalence of metabolic syndrome parameters in a Roma-nian population of young adults. Rev Romana Med Lab 2012; 20(3): 21-28.
22. Tantu MM, Man GM, Paunescu A, et al. Corelations Between the Use of Medical Substances and the Incidence Infections Produced by Clostridium Difficile Species. Rev Chim 2018; 69(11): 3001-3005.
23. Nemes RM, Pop CS, Calagiu D, Dobrin D, Chetroiu D, Jantea P, Postolache P. Anemia in Inflamma-tory Bowel Disease More Than an Extraintestinal Complication. Rev Med Chir Soc Med Nat Iasi 2016; 120(1): 34-39.
24. Nicolae C. Evaluation of histophysiology alterations associated with ketoprophen administration in albino mice. Farmacia 2019; 1: 1-10.
25. Nicolae C. Use of anticoagulants in cerebral vascular pathology. Farmacia 2019; 1: 11-20.
26. Nicolae C. Identification of Lynch syndrome risk variants in the Romanian population. J Cell Mol Med 2018; 22(12): 6068-6076.
27. Stefanescu DC, Ceachir O, Zainea V, Hainarosie M, Pietrosanu C, Ionita IG, Hainarosie R. The Use of Methylene Blue in Assessing Disease Free Margins During CO2 LASER Assisted Direct Laryn-goscopy for Glottis Cancer. Rev Chim 2016; 67(7): 1327-1328.
28. Stefanescu DC, Ceachir O, Zainea V, Hainarosie M, Pietrosanu C, Ionita IG, Hainarosie R. The Value of Toluidine Blue Staining Test in Assessing Disease Free Margins of Oral Cavity Carcinomas. Rev Chim 2016; 67(7): 1255-1256.
29. Jimborean G, Ianosi ES, Comes AD, Gurzu S, Nițu MF, Lupuț GD, Mezei T, Borz OC. Neuroendo-crine pancreatic tumor-diagnosis circumstances, staging and treatment: a case report. Romanian J Morphol Embryol 2015; 56(2): 619-622.
30. Postolica R, Iorga M, Petrariu FD, Azoicai D. Cognitive-Behavioral Coping, Illness Perception, and Family Adaptability in Oncological Patients with a Family History of Cancer. BioMed Research In-ternational Volume 2017, Article ID 8104397, https://doi.org/10.1155/2017/8104397.
31. Raşcu A, Naghi E, Oțelea MR, Nițu FM, Arghir OC. Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report. Rom J Morphol Embryol 2016; 57(3): 1171-1174.
32. Postolache P, Nemes RM, Petrescu O, et al. Smoking cessation, pulmonary rehabilitation and quality of life of smokers with COPD. Rev Med Chir Soc Med Nat Iasi 2015; 119(1): 77-80.
33. Nemes RM, Postolache P, Tintila A et al. Aspects of physician - patient communication in the program of smoking cessation. Rev Med Chir Soc Med Nat Iasi 2015; 119: 23-30.
34. Nomura AMY, Wilkens LR, Henderson BE, Epplein M, Kolonel LN. The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes Control 2012; 23(1): 51-58.
35. Camargo MC, Piazuelo MB et al. Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia. Acta Gastroenterol Latinoam 2007; 37(4): 238-245.
36. Jimborean G, Ianosi ES, Csipor A, Postolache P. Training the future trainers-intensifying anti-smoking education for a better community health. Rev Chim (Bucharest) 2017; 68(9): 2129-2131.

Additional Files

Published

2019-03-29

Issue

Section

INTERNAL MEDICINE - PEDIATRICS